Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 76147-76152 [2024-21062]
Download as PDF
<![CDATA[
76147
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
or the sale within the United States after
importation of components for certain
environmentally-protected LCD digital
displays and products containing same
by reason of infringement of certain
claims of U.S. Patent Nos. 7,948,575
(‘‘the ’575 patent’’); 8,111,348 (‘‘the ’348
patent’’); RE45,117 (‘‘the ’117 patent’’);
8,842,253 (‘‘the ’253 patent’’); and
8,223,311 (‘‘the ’311 patent’’). Id. The
Commission’s notice of investigation
named Manufacturing Resources
International, Inc. (‘‘MRI’’) of
Alpharetta, Georgia as the sole
respondent. The Office of Unfair Import
Investigations was not named as a party
in this investigation. Id.
On October 10, 2023, the Commission
determined not to review an initial
determination terminating the
investigation as to all asserted claims of
the ’575 patent; all asserted claims of
the ’348 patent; claim 5 of the ’117
patent; claims 1, 10, 11, and 16–19 of
the ’253 patent; and claims 1–3 and 7–
12 of the ’311 patent. Order No. 22,
unreviewed by Comm’n Notice (Oct. 10,
2023).
On April 16, 2024, the presiding
administrative law judge issued a final
initial determination (‘‘final ID’’) on
violation of section 337 and a
recommended determination on remedy
and bond. The final ID held that no
violation of section 337 has occurred in
the importation into the United States,
the sale for importation, or the sale
within the United States after
importation of components of certain
environmentally-protected LCD digital
displays and products containing the
same by reason of infringement of
claims 1 and 2 of the ’117 patent, claims
4, 6, and 13 of the ’311 patent, and
claim 12 of the ’253 patent.
On June 17, 2024, the Commission
determined to review the final ID in
part. See 89 FR 52505 (June 24, 2024).
The Commission asked the parties to
address a number of questions related to
the issues under review. Id. at 52506–
07.
On July 1, 2024, Samsung and MRI
each filed an initial written response to
the Commission’s request for briefing.
On July 9, 2024, the parties each filed
a reply submission.
On August 13, 2024, the parties filed
a Joint Motion to Stay Investigation and
Extend Target Date. The parties stated
they have agreed to resolve the
investigation based on the terms of the
Binding Term Sheet (Ex. A), but
requested that the Commission stay the
investigation and extend the target date
to August 30, 2024, to allow the parties
time to execute a final settlement
agreement and file a motion to terminate
the investigation. The Commission
granted the motion, stayed the
investigation, and extended the target
date for completion of the investigation
to September 16, 2024. Comm’n Notice
(Aug. 16, 2024).
On August 28, 2024, the parties filed
a Joint Motion for Termination by
Settlement (‘‘Motion’’). The parties
submitted the executed settlement
agreement as Exhibit A to the Motion.
The Commission has determined that
the Motion complies with the
requirements of Rule 210.21(b)(1) of the
Commission’s Rules of Practice and
Procedure (19 CFR 210.21(b)(1)), and
that there are no extraordinary
circumstances that would prevent the
requested termination. The Commission
also finds that granting the Motion
would not be contrary to the public
interest pursuant to Rule 210.50(b)(2) of
the Commission’s Rules of Practice and
Procedure (19 CFR 210.50(b)(2)).
Accordingly, the Commission hereby
grants the Motion. The Commission
takes no position as to the issues that
remain under review.
This investigation is terminated.
The Commission vote for this
determination took place on September
12, 2024.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and in part 210 of the Commission’s
Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: September 12, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–21114 Filed 9–16–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1431]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chemtos, LLC has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 18, 2024. Such
persons may also file a written request
for a hearing on the application on or
before November 18, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 5, 2024,
Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664–8544,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Drug
code
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Amineptine ...................................................................................................................................................................................
Mesocarb .....................................................................................................................................................................................
3-Fluoro-N-methylcathinone (3–FMC) .........................................................................................................................................
Cathinone ....................................................................................................................................................................................
Methcathinone .............................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .........................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...............................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ................................................................................................................................
VerDate Sep<11>2014
17:12 Sep 16, 2024
Jkt 262001
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
E:\FR\FM\17SEN1.SGM
17SEN1
1219
1227
1233
1235
1237
1238
1246
1248
Schedule
I
I
I
I
I
I
I
I
76148
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
Drug
code
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
4-Methyl-N-ethylcathinone (4–MEC) ...........................................................................................................................................
Naphyrone ...................................................................................................................................................................................
3–MMC; 3–METHYLMETHCATHINONE ....................................................................................................................................
N-Ethylamphetamine ...................................................................................................................................................................
Methiopropamine .........................................................................................................................................................................
N,N-Dimethylamphetamine ..........................................................................................................................................................
Fenethylline .................................................................................................................................................................................
Aminorex ......................................................................................................................................................................................
4-Methylaminorex (cis isomer) ....................................................................................................................................................
Gamma Hydroxybutyric Acid .......................................................................................................................................................
Methaqualone ..............................................................................................................................................................................
Mecloqualone ..............................................................................................................................................................................
ETIZOLAM ...................................................................................................................................................................................
FLUALPRAZOLAM ......................................................................................................................................................................
CLONAZOLAM ............................................................................................................................................................................
FLUBROMAZOLAM ....................................................................................................................................................................
DICLAZEPAM ..............................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..............................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ............................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .........................
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ............................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................................
FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ...........................................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..................................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..................................
FUB–AMB, MMB- FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ......
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .....................................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ...............................................................................
5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ....................................
ADB–BUTINACA .........................................................................................................................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide .............................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ....................
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..........................................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..................
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .............................................
5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .....................................
5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..........................................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ......
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ....................
FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..........................................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..............................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..............................................................................................................
5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ................................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ...........................
4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1-(4cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
4F–MDMB–BUTICA; 4F–MDMB–BICA .......................................................................................................................................
ADB–4EN–PINACA .....................................................................................................................................................................
CUMYL–PEGACLONE; SGT–151 ..............................................................................................................................................
5F–EDMB–PICA; 5F–EDMB–2201 .............................................................................................................................................
MMB–FUBICA .............................................................................................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..........................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .................................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .............................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...................................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ......................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...................................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..................................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ......................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .............................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ........................................................................................
4–MEAP (4-Methyl-alpha-ethylaminopentiophenone) .................................................................................................................
N-Ethylhexedrone ........................................................................................................................................................................
Alpha-ethyltryptamine ..................................................................................................................................................................
Ibogaine .......................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ............................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ......................................................
Lysergic acid diethylamide ..........................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ..........................................................................................................
Marihuana Extract .......................................................................................................................................................................
VerDate Sep<11>2014
17:12 Sep 16, 2024
Jkt 262001
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
E:\FR\FM\17SEN1.SGM
17SEN1
Schedule
1249
1258
1259
1475
1478
1480
1503
1585
1590
2010
2565
2572
2780
2785
2786
2788
2789
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
7024
7025
7027
7031
7032
7033
7034
7035
7036
7041
7042
7044
7047
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7091
7092
7093
7094
7095
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
76149
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
Drug
code
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Marihuana ....................................................................................................................................................................................
Tetrahydrocannabinols ................................................................................................................................................................
Parahexyl .....................................................................................................................................................................................
Mescaline .....................................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ......................................................................................................
3,4,5-Trimethoxyamphetamine ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .........................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ......................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .........................................................................................................................................
2,5-Dimethoxyamphetamine ........................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..................................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ............................................................................................................................................
3,4-Methylenedioxyamphetamine ................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..............................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..............................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...................................................................................................................................
3,4-Methylenedioxymethamphetamine ........................................................................................................................................
4-Methoxyamphetamine ..............................................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ............................................................................................................................................
Alpha-methyltryptamine ...............................................................................................................................................................
Bufotenine ....................................................................................................................................................................................
Diethyltryptamine .........................................................................................................................................................................
Dimethyltryptamine ......................................................................................................................................................................
Psilocybin .....................................................................................................................................................................................
Psilocyn .......................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .........................................................................................................................................
4′-Chloro-alpha-pyrrolidinovalerophenone ...................................................................................................................................
MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone .......................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ................................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ..........................................................................................................................................
N-Ethyl-3-piperidyl benzilate ........................................................................................................................................................
N-Methyl-3-piperidyl benzilate .....................................................................................................................................................
N-Benzylpiperazine ......................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .................................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..............................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ................................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .............................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ....................................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ..............................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ................................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .........................................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ..............................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...................................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ................................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ................................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) .....................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..................................................................................................................
Butylone .......................................................................................................................................................................................
Pentylone .....................................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .................................................................
a-PHP, alpha-Pyrrolidinohexanophenone ...................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ....................................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ......................................................................................................................................
Ethylone .......................................................................................................................................................................................
Eutylone .......................................................................................................................................................................................
A–PIHP; ALPHA–PIHP ................................................................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...............................................................................................................
Acetyldihydrocodeine ...................................................................................................................................................................
Benzylmorphine ...........................................................................................................................................................................
Codeine-N-oxide ..........................................................................................................................................................................
Cyprenorphine .............................................................................................................................................................................
Desomorphine .............................................................................................................................................................................
Etorphine (except HCl) ................................................................................................................................................................
Codeine methylbromide ...............................................................................................................................................................
Brorphine .....................................................................................................................................................................................
Dihydromorphine .........................................................................................................................................................................
Difenoxin ......................................................................................................................................................................................
Heroin ..........................................................................................................................................................................................
Hydromorphinol ...........................................................................................................................................................................
Methyldesorphine ........................................................................................................................................................................
Methyldihydromorphine ...............................................................................................................................................................
VerDate Sep<11>2014
17:12 Sep 16, 2024
Jkt 262001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
E:\FR\FM\17SEN1.SGM
17SEN1
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7549
7551
7694
9051
9052
9053
9054
9055
9056
9070
9098
9145
9168
9200
9301
9302
9304
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
76150
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
Drug
code
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Morphine methylbromide .............................................................................................................................................................
Morphine methylsulfonate ...........................................................................................................................................................
Morphine-N-oxide ........................................................................................................................................................................
Myrophine ....................................................................................................................................................................................
Nicocodeine .................................................................................................................................................................................
Nicomorphine ...............................................................................................................................................................................
Normorphine ................................................................................................................................................................................
Pholcodine ...................................................................................................................................................................................
Thebacon .....................................................................................................................................................................................
Acetorphine ..................................................................................................................................................................................
Drotebanol ...................................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..........................................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..............................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ..............................................................................................................
Acetylmethadol ............................................................................................................................................................................
Allylprodine ..................................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..................................................................................................................
Alphameprodine ...........................................................................................................................................................................
Alphamethadol .............................................................................................................................................................................
Benzethidine ................................................................................................................................................................................
Betacetylmethadol .......................................................................................................................................................................
Betameprodine ............................................................................................................................................................................
Betamethadol ...............................................................................................................................................................................
Betaprodine .................................................................................................................................................................................
Clonitazene ..................................................................................................................................................................................
Dextromoramide ..........................................................................................................................................................................
Isotonitazene ...............................................................................................................................................................................
Diampromide ...............................................................................................................................................................................
Diethylthiambutene ......................................................................................................................................................................
Dimenoxadol ................................................................................................................................................................................
Dimepheptanol .............................................................................................................................................................................
Dimethylthiambutene ...................................................................................................................................................................
Dioxaphetyl butyrate ....................................................................................................................................................................
Dipipanone ...................................................................................................................................................................................
Ethylmethylthiambutene ..............................................................................................................................................................
Etonitazene ..................................................................................................................................................................................
Etoxeridine ...................................................................................................................................................................................
Furethidine ...................................................................................................................................................................................
Hydroxypethidine .........................................................................................................................................................................
Ketobemidone ..............................................................................................................................................................................
Levomoramide .............................................................................................................................................................................
Levophenacylmorphan ................................................................................................................................................................
Morpheridine ................................................................................................................................................................................
Noracymethadol ...........................................................................................................................................................................
Norlevorphanol ............................................................................................................................................................................
Normethadone .............................................................................................................................................................................
Norpipanone ................................................................................................................................................................................
Phenadoxone ...............................................................................................................................................................................
Phenampromide ..........................................................................................................................................................................
Phenoperidine ..............................................................................................................................................................................
Piritramide ....................................................................................................................................................................................
Proheptazine ................................................................................................................................................................................
Properidine ..................................................................................................................................................................................
Racemoramide ............................................................................................................................................................................
Trimeperidine ...............................................................................................................................................................................
Phenomorphan ............................................................................................................................................................................
Propiram ......................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..................................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ..........................................................................................................................
Tilidine .........................................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .............................................................................................
Para-Fluorofentanyl .....................................................................................................................................................................
3-Methylfentanyl ..........................................................................................................................................................................
Alpha-methylfentanyl ...................................................................................................................................................................
Acetyl-alpha-methylfentanyl .........................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...................................................................................................
Para-Methylfentanyl .....................................................................................................................................................................
4′-Methyl Acetyl Fentanyl ............................................................................................................................................................
Ortho-Methyl Methoxyacetyl Fentanyl .........................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...........................................................................................
Butyryl Fentanyl ...........................................................................................................................................................................
Para-fluorobutyryl fentanyl ...........................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .....................................................
VerDate Sep<11>2014
17:12 Sep 16, 2024
Jkt 262001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
E:\FR\FM\17SEN1.SGM
17SEN1
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9614
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9816
9817
9819
9820
9821
9822
9823
9824
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
76151
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
Drug
code
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .....................................................................................................
Para-chloroisobutyryl fentanyl .....................................................................................................................................................
Isobutyryl fentanyl ........................................................................................................................................................................
Beta-hydroxyfentanyl ...................................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ....................................................................................................................................................
Alpha-methylthiofentanyl .............................................................................................................................................................
3-Methylthiofentanyl .....................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .........................................................................
Thiofentanyl .................................................................................................................................................................................
Beta-hydroxythiofentanyl .............................................................................................................................................................
Para-methoxybutyryl fentanyl ......................................................................................................................................................
Ocfentanil .....................................................................................................................................................................................
Thiofuranyl Fentanyl ....................................................................................................................................................................
Valeryl fentanyl ............................................................................................................................................................................
Phenyl fentanyl ............................................................................................................................................................................
Beta’-Phenyl fentanyl ...................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ......................................................................................
Crotonyl Fentanyl ........................................................................................................................................................................
Cyclopropyl Fentanyl ...................................................................................................................................................................
Ortho-Fluorobutyryl Fentanyl .......................................................................................................................................................
Cyclopentyl Fentanyl ...................................................................................................................................................................
Ortho-Methyl Acetylfentanyl ........................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .................................................................................................
Fentanyl Carbamate ....................................................................................................................................................................
Ortho-Fluoracryl Fentanyl ............................................................................................................................................................
Ortho-Fluoroisobutyryl Fentanyl ..................................................................................................................................................
Para-Fluoro Furanyl Fentanyl ......................................................................................................................................................
2′-Fluoro ortho-fluorofentanyl ......................................................................................................................................................
Beta-Methyl Fentanyl ...................................................................................................................................................................
Zipeprol ........................................................................................................................................................................................
Amphetamine ...............................................................................................................................................................................
Methamphetamine .......................................................................................................................................................................
Lisdexamfetamine ........................................................................................................................................................................
Phenmetrazine .............................................................................................................................................................................
Methylphenidate ..........................................................................................................................................................................
Amobarbital ..................................................................................................................................................................................
Pentobarbital ................................................................................................................................................................................
Secobarbital .................................................................................................................................................................................
Glutethimide .................................................................................................................................................................................
Nabilone .......................................................................................................................................................................................
1-Phenylcyclohexylamine ............................................................................................................................................................
Phencyclidine ...............................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .................................................................................................................................
Norfentanyl ..................................................................................................................................................................................
Phenylacetone .............................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ............................................................................................................................................
Alphaprodine ................................................................................................................................................................................
Anileridine ....................................................................................................................................................................................
Cocaine ........................................................................................................................................................................................
Codeine .......................................................................................................................................................................................
Etorphine HCl ..............................................................................................................................................................................
Dihydrocodeine ............................................................................................................................................................................
Oxycodone ...................................................................................................................................................................................
Hydromorphone ...........................................................................................................................................................................
Diphenoxylate ..............................................................................................................................................................................
Ecgonine ......................................................................................................................................................................................
Ethylmorphine ..............................................................................................................................................................................
Hydrocodone ...............................................................................................................................................................................
Levomethorphan ..........................................................................................................................................................................
Levorphanol .................................................................................................................................................................................
Isomethadone ..............................................................................................................................................................................
Meperidine ...................................................................................................................................................................................
Meperidine intermediate-A ..........................................................................................................................................................
Meperidine intermediate-B ..........................................................................................................................................................
Meperidine intermediate-C ..........................................................................................................................................................
Metazocine ..................................................................................................................................................................................
Oliceridine ....................................................................................................................................................................................
Methadone ...................................................................................................................................................................................
Methadone intermediate ..............................................................................................................................................................
Metopon .......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..........................................................................................................................
Morphine ......................................................................................................................................................................................
Oripavine .....................................................................................................................................................................................
VerDate Sep<11>2014
17:12 Sep 16, 2024
Jkt 262001
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
E:\FR\FM\17SEN1.SGM
17SEN1
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9839
9840
9841
9842
9843
9844
9845
9846
9847
9848
9850
9851
9852
9853
9854
9855
9856
9873
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8366
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9245
9250
9254
9260
9273
9300
9330
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
76152
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices
Drug
code
Controlled substance
Thebaine ......................................................................................................................................................................................
Dihydroetorphine .........................................................................................................................................................................
Levo-alphacetylmethadol .............................................................................................................................................................
Oxymorphone ..............................................................................................................................................................................
Noroxymorphone .........................................................................................................................................................................
Phenazocine ................................................................................................................................................................................
Thiafentanil ..................................................................................................................................................................................
Piminodine ...................................................................................................................................................................................
Racemethorphan .........................................................................................................................................................................
Racemorphan ..............................................................................................................................................................................
Alfentanil ......................................................................................................................................................................................
Remifentanil .................................................................................................................................................................................
Sufentanil .....................................................................................................................................................................................
Carfentanil ...................................................................................................................................................................................
Tapentadol ...................................................................................................................................................................................
Bezitramide ..................................................................................................................................................................................
Fentanyl .......................................................................................................................................................................................
Moramide-intermediate ................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for distribution to its
customers. In reference to dug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–21062 Filed 9–16–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1432]
Bulk Manufacturer of Controlled
Substances Application: Eli-Elsohly
Laboratories
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 16, 2024, EliElsohly Laboratories, 5 Industrial Park
Drive, Oxford, Mississippi 38655–5343,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
AGENCY:
Eli-Elsohly Laboratories has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 18, 2024. Such
persons may also file a written request
for a hearing on the application on or
before November 18, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
VerDate Sep<11>2014
17:12 Sep 16, 2024
Jkt 262001
Marihuana Extract ..........
Marihuana .......................
Tetrahydrocannabinols ...
Dihydromorphine ............
Amphetamine .................
Methamphetamine ..........
Cocaine ..........................
Codeine ..........................
Dihydrocodeine ...............
Oxycodone .....................
Ecgonine .........................
Thebaine .........................
Drug
code
Schedule
7350
7360
7370
9145
1100
1105
9041
9050
9120
9143
9180
9333
I
I
I
I
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for
product development reference
standards. In reference to drug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to isolate these controlled
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
substances from procured 7350
(Marihuana Extract). In reference to
drug code 7360, no cultivation activities
are authorized for this registration.
In reference to drug code 9333
(Thebaine), the company plans to
manufacture a Thebaine derivative. No
other activities for these drug codes are
authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–21060 Filed 9–16–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 23–53]
George D. Gowder, III, M.D.; Decision
and Order
On July 18, 2023, the Drug
Enforcement Administration (DEA or
Government) issued an Order to Show
Cause (OSC) to George Gowder, III,
M.D., of Blairsville, Georgia
(Respondent). OSC, at 1, 3. The OSC
proposed the denial of Respondent’s
application for a DEA Certificate of
Registration (registration), Control No.
W22147308C, alleging that Respondent
has been convicted of a felony relating
to Federal controlled substance laws,
and that he has been excluded from
participation in Medicare, Medicaid,
and all Federal health care programs. Id.
at 1–2 (citing 21 U.S.C. 823(g)(1),
824(a)(2), 824(a)(5)).
A hearing was held before DEA
Administrative Law Judge Teresa A.
Wallbaum (ALJ), who, on December 1,
2023, issued her Recommended Rulings,
Findings of Fact, Conclusions of Law,
and Decision (Recommended Decision
or RD). The RD recommended that
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 89, Number 180 (Tuesday, September 17, 2024)]
[Notices]
[Pages 76147-76152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21062]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1431]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chemtos, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 18, 2024. Such persons may also file a written request for a
hearing on the application on or before November 18, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 5, 2024, Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664-8544, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amineptine................................... 1219 I
Mesocarb..................................... 1227 I
3-Fluoro-N-methylcathinone (3-FMC)........... 1233 I
Cathinone.................................... 1235 I
Methcathinone................................ 1237 I
4-Fluoro-N-methylcathinone (4-FMC)........... 1238 I
Pentedrone ([alpha]-methylaminovalerophenone) 1246 I
Mephedrone (4-Methyl-N-methylcathinone)...... 1248 I
[[Page 76148]]
4-Methyl-N-ethylcathinone (4-MEC)............ 1249 I
Naphyrone.................................... 1258 I
3-MMC; 3-METHYLMETHCATHINONE................. 1259 I
N-Ethylamphetamine........................... 1475 I
Methiopropamine.............................. 1478 I
N,N-Dimethylamphetamine...................... 1480 I
Fenethylline................................. 1503 I
Aminorex..................................... 1585 I
4-Methylaminorex (cis isomer)................ 1590 I
Gamma Hydroxybutyric Acid.................... 2010 I
Methaqualone................................. 2565 I
Mecloqualone................................. 2572 I
ETIZOLAM..................................... 2780 I
FLUALPRAZOLAM................................ 2785 I
CLONAZOLAM................................... 2786 I
FLUBROMAZOLAM................................ 2788 I
DICLAZEPAM................................... 2789 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-methoxyphenylacetyl)
indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7012 I
yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3- 7014 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)...... 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)- 7020 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-(1-(4- 7021 I
fluorobenzyl)-1Hindazole-3-carboxamido)-3-
methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone.
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan- 7025 I
2-yl)-1-(5-fluropentyl)-1H-indazole-3-
carboximide).
ADB-BUTINACA................................. 7027 ................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I
yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)- 7036 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H- 7041 I
indole-3-carboxamido)-3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-carboxamido)-
3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-carboxamido)-
3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- 7048 I
indazole-3-carboxamide.
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I
fluoropentyl)-1H-indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N- 7083 I
(2-phenylpropan-2-yl)-1H-indazole-3-
carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I
phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-
3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4- 7089 I
CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-
(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-
indazole-3-carboxamide).
4F-MDMB-BUTICA; 4F-MDMB-BICA................. 7091 I
ADB-4EN-PINACA............................... 7092 I
CUMYL-PEGACLONE; SGT-151..................... 7093 I
5F-EDMB-PICA; 5F-EDMB-2201................... 7094 I
MMB-FUBICA................................... 7095 I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)...... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H- 7225 I
indole-3-carboxylate).
4-MEAP (4-Methyl-alpha- 7245 I
ethylaminopentiophenone).
N-Ethylhexedrone............................. 7246 I
Alpha-ethyltryptamine........................ 7249 I
Ibogaine..................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)- 7297 I
3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)- 7298 I
2-[(1R,3S)3-hydroxycyclohexyl-phenol).
Lysergic acid diethylamide................... 7315 I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine 7348 I
(2C-T-7).
Marihuana Extract............................ 7350 I
[[Page 76149]]
Marihuana.................................... 7360 I
Tetrahydrocannabinols........................ 7370 I
Parahexyl.................................... 7374 I
Mescaline.................................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine.................. 7390 I
4-Bromo-2,5-dimethoxyamphetamine............. 7391 I
4-Bromo-2,5-dimethoxyphenethylamine.......... 7392 I
4-Methyl-2,5-dimethoxyamphetamine............ 7395 I
2,5-Dimethoxyamphetamine..................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
2,5-Dimethoxy-4-ethylamphetamine............. 7399 I
3,4-Methylenedioxyamphetamine................ 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine...... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine...... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine........ 7404 I
3,4-Methylenedioxymethamphetamine............ 7405 I
4-Methoxyamphetamine......................... 7411 I
5-Methoxy-N-N-dimethyltryptamine............. 7431 I
Alpha-methyltryptamine....................... 7432 I
Bufotenine................................... 7433 I
Diethyltryptamine............................ 7434 I
Dimethyltryptamine........................... 7435 I
Psilocybin................................... 7437 I
Psilocyn..................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine.......... 7439 I
4'-Chloro-alpha-pyrrolidinovalerophenone..... 7443 I
MPHP, 4'-Methyl-alpha-pyrrolidinohexiophenone 7446 I
N-Ethyl-1-phenylcyclohexylamine.............. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine............ 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine........ 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine....... 7473 I
N-Ethyl-3-piperidyl benzilate................ 7482 I
N-Methyl-3-piperidyl benzilate............... 7484 I
N-Benzylpiperazine........................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine 7508 I
(2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine 7509 I
(2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).... 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C- 7518 I
I).
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine 7519 I
(2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine 7521 I
(2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I
ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone)........ 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone..................................... 7541 I
Pentylone.................................... 7542 I
N-Ethypentylone, ephylone (1-(1,3-benzodioxol- 7543 I
5-yl)-2-(ethylamino)-pentan-1-one).
[alpha]-PHP, alpha-Pyrrolidinohexanophenone.. 7544 I
alpha-pyrrolidinopentiophenone ([alpha]-PVP). 7545 I
alpha-pyrrolidinobutiophenone ([alpha]-PBP).. 7546 I
Ethylone..................................... 7547 I
Eutylone..................................... 7549 I
A-PIHP; ALPHA-PIHP........................... 7551 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 7694 I
indole).
Acetyldihydrocodeine......................... 9051 I
Benzylmorphine............................... 9052 I
Codeine-N-oxide.............................. 9053 I
Cyprenorphine................................ 9054 I
Desomorphine................................. 9055 I
Etorphine (except HCl)....................... 9056 I
Codeine methylbromide........................ 9070 I
Brorphine.................................... 9098 I
Dihydromorphine.............................. 9145 I
Difenoxin.................................... 9168 I
Heroin....................................... 9200 I
Hydromorphinol............................... 9301 I
Methyldesorphine............................. 9302 I
Methyldihydromorphine........................ 9304 I
[[Page 76150]]
Morphine methylbromide....................... 9305 I
Morphine methylsulfonate..................... 9306 I
Morphine-N-oxide............................. 9307 I
Myrophine.................................... 9308 I
Nicocodeine.................................. 9309 I
Nicomorphine................................. 9312 I
Normorphine.................................. 9313 I
Pholcodine................................... 9314 I
Thebacon..................................... 9315 I
Acetorphine.................................. 9319 I
Drotebanol................................... 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol............................... 9601 I
Allylprodine................................. 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine............................... 9604 I
Alphamethadol................................ 9605 I
Benzethidine................................. 9606 I
Betacetylmethadol............................ 9607 I
Betameprodine................................ 9608 I
Betamethadol................................. 9609 I
Betaprodine.................................. 9611 I
Clonitazene.................................. 9612 I
Dextromoramide............................... 9613 I
Isotonitazene................................ 9614 I
Diampromide.................................. 9615 I
Diethylthiambutene........................... 9616 I
Dimenoxadol.................................. 9617 I
Dimepheptanol................................ 9618 I
Dimethylthiambutene.......................... 9619 I
Dioxaphetyl butyrate......................... 9621 I
Dipipanone................................... 9622 I
Ethylmethylthiambutene....................... 9623 I
Etonitazene.................................. 9624 I
Etoxeridine.................................. 9625 I
Furethidine.................................. 9626 I
Hydroxypethidine............................. 9627 I
Ketobemidone................................. 9628 I
Levomoramide................................. 9629 I
Levophenacylmorphan.......................... 9631 I
Morpheridine................................. 9632 I
Noracymethadol............................... 9633 I
Norlevorphanol............................... 9634 I
Normethadone................................. 9635 I
Norpipanone.................................. 9636 I
Phenadoxone.................................. 9637 I
Phenampromide................................ 9638 I
Phenoperidine................................ 9641 I
Piritramide.................................. 9642 I
Proheptazine................................. 9643 I
Properidine.................................. 9644 I
Racemoramide................................. 9645 I
Trimeperidine................................ 9646 I
Phenomorphan................................. 9647 I
Propiram..................................... 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine..... 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine..................................... 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)- 9811 I
N-phenylacrylamide).
Para-Fluorofentanyl.......................... 9812 I
3-Methylfentanyl............................. 9813 I
Alpha-methylfentanyl......................... 9814 I
Acetyl-alpha-methylfentanyl.................. 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I
yl)propionamide.
Para-Methylfentanyl.......................... 9817 I
4'-Methyl Acetyl Fentanyl.................... 9819 I
Ortho-Methyl Methoxyacetyl Fentanyl.......... 9820 I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl............................. 9822 I
Para-fluorobutyryl fentanyl.................. 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
[[Page 76151]]
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Para-chloroisobutyryl fentanyl............... 9826 I
Isobutyryl fentanyl.......................... 9827 I
Beta-hydroxyfentanyl......................... 9830 I
Beta-hydroxy-3-methylfentanyl................ 9831 I
Alpha-methylthiofentanyl..................... 9832 I
3-Methylthiofentanyl......................... 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl................................. 9835 I
Beta-hydroxythiofentanyl..................... 9836 I
Para-methoxybutyryl fentanyl................. 9837 I
Ocfentanil................................... 9838 I
Thiofuranyl Fentanyl......................... 9839 I
Valeryl fentanyl............................. 9840 I
Phenyl fentanyl.............................. 9841 I
Beta'-Phenyl fentanyl........................ 9842 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Crotonyl Fentanyl............................ 9844 I
Cyclopropyl Fentanyl......................... 9845 I
Ortho-Fluorobutyryl Fentanyl................. 9846 I
Cyclopentyl Fentanyl......................... 9847 I
Ortho-Methyl Acetylfentanyl.................. 9848 I
Fentanyl related-compounds as defined in 21 9850 I
CFR 1308.11(h).
Fentanyl Carbamate........................... 9851 I
Ortho-Fluoracryl Fentanyl.................... 9852 I
Ortho-Fluoroisobutyryl Fentanyl.............. 9853 I
Para-Fluoro Furanyl Fentanyl................. 9854 I
2'-Fluoro ortho-fluorofentanyl............... 9855 I
Beta-Methyl Fentanyl......................... 9856 I
Zipeprol..................................... 9873 I
Amphetamine.................................. 1100 II
Methamphetamine.............................. 1105 II
Lisdexamfetamine............................. 1205 II
Phenmetrazine................................ 1631 II
Methylphenidate.............................. 1724 II
Amobarbital.................................. 2125 II
Pentobarbital................................ 2270 II
Secobarbital................................. 2315 II
Glutethimide................................. 2550 II
Nabilone..................................... 7379 II
1-Phenylcyclohexylamine...................... 7460 II
Phencyclidine................................ 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP).... 8333 II
Norfentanyl.................................. 8366 II
Phenylacetone................................ 8501 II
1-Piperidinocyclohexanecarbonitrile.......... 8603 II
Alphaprodine................................. 9010 II
Anileridine.................................. 9020 II
Cocaine...................................... 9041 II
Codeine...................................... 9050 II
Etorphine HCl................................ 9059 II
Dihydrocodeine............................... 9120 II
Oxycodone.................................... 9143 II
Hydromorphone................................ 9150 II
Diphenoxylate................................ 9170 II
Ecgonine..................................... 9180 II
Ethylmorphine................................ 9190 II
Hydrocodone.................................. 9193 II
Levomethorphan............................... 9210 II
Levorphanol.................................. 9220 II
Isomethadone................................. 9226 II
Meperidine................................... 9230 II
Meperidine intermediate-A.................... 9232 II
Meperidine intermediate-B.................... 9233 II
Meperidine intermediate-C.................... 9234 II
Metazocine................................... 9240 II
Oliceridine.................................. 9245 II
Methadone.................................... 9250 II
Methadone intermediate....................... 9254 II
Metopon...................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms).. 9273 II
Morphine..................................... 9300 II
Oripavine.................................... 9330 II
[[Page 76152]]
Thebaine..................................... 9333 II
Dihydroetorphine............................. 9334 II
Levo-alphacetylmethadol...................... 9648 II
Oxymorphone.................................. 9652 II
Noroxymorphone............................... 9668 II
Phenazocine.................................. 9715 II
Thiafentanil................................. 9729 II
Piminodine................................... 9730 II
Racemethorphan............................... 9732 II
Racemorphan.................................. 9733 II
Alfentanil................................... 9737 II
Remifentanil................................. 9739 II
Sufentanil................................... 9740 II
Carfentanil.................................. 9743 II
Tapentadol................................... 9780 II
Bezitramide.................................. 9800 II
Fentanyl..................................... 9801 II
Moramide-intermediate........................ 9802 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for distribution to its customers. In reference to dug codes
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans
to bulk manufacture these drugs as synthetic. No other activities for
these drug codes are authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-21062 Filed 9-16-24; 8:45 am]
BILLING CODE 4410-09-P
